We're Struggling to Conceive

If you are struggling to conceive, this guide explains the male fertility assessment, possible causes and options, with links to more detailed guides.

If you're reading this, you may be experiencing one of life's most challenging struggles. I want you to know you're not alone, and there is hope.

Around 1 in 7 couples in the UK have difficulty conceiving, and a sperm-related (male) factor is found in around half of them. Despite these numbers, many men feel isolated in their experience, often suffering in silence due to outdated societal perceptions about masculinity and fertility.

My mission is to change that narrative through education, compassionate care, and effective treatment. Throughout my career, I've witnessed the profound impact that proper diagnosis and treatment can have, transforming anxiety and disappointment into hope and, often, the joy of parenthood.

Concerned about your fertility?

Book a comprehensive male fertility assessment with our specialist team.

What is Male Factor Infertility?

Simply put, male factor infertility occurs when aspects of a man's reproductive health prevent a couple from achieving pregnancy. This can involve issues with sperm production, sperm function, or sperm delivery.

In my clinic, we define infertility as the inability to conceive after 12 months of regular, unprotected intercourse (or 6 months if the female partner is over 35). For men, this typically manifests as issues with sperm quantity, quality, or the ability to deliver sperm to the egg.

Many men are surprised to learn that male fertility is a complex process involving multiple systems in the body. Disruptions at any stage—from hormone production to sperm maturation to ejaculation—can impact fertility. Understanding which part of the process is affected is the first step toward effective treatment.

Male fertility requires several complex biological systems to function optimally:

1. Hormonal Regulation: The hypothalamic-pituitary-gonadal axis controls the production of testosterone, FSH (follicle-stimulating hormone), and LH (luteinising hormone) - critical hormones that regulate sperm production.
1. Spermatogenesis: The process of sperm cell development takes approximately 74 days. This occurs within the seminiferous tubules of the testes, where specialised Sertoli cells support developing sperm cells. A complete cycle of sperm development takes about 3 months, which is why lifestyle changes or medical interventions need time to demonstrate effects.
1. Sperm Maturation: After formation, sperm cells travel to the epididymis for final maturation, where they develop motility and fertilisation capabilities over approximately 12 days.
1. Sperm Transport: Mature sperm are stored in the epididymis until ejaculation, when they mix with secretions from the seminal vesicles, prostate, and bulbourethral glands to form semen.
1. Fertilisation Capacity: For successful fertilisation, sperm must travel through the female reproductive tract, undergo capacitation (a process that enables penetration of the egg), and finally, the acrosome reaction (which allows the sperm to penetrate the egg's outer layer).

Any disruption to these complex processes can result in male factor infertility, ranging from reduced sperm production to impaired sperm function.

Common Causes of Male Infertility

Male infertility typically stems from issues with sperm quantity, quality, or delivery. In my practice, I commonly see fertility challenges arising from several key areas.

Sperm production problems, including genetic factors, represent a significant cause of infertility. These range from mild reductions in sperm count to complete absence of sperm. Hormone imbalances also play a crucial role, as the delicate endocrine system that regulates sperm production can be disrupted by various conditions.

Structural abnormalities such as varicoceles—enlarged veins in the scrotum—affect about 15% of men but contribute to up to 40% of male infertility cases. These can raise testicular temperature and impact sperm production. Sperm transport blockages, whether congenital or acquired through infection or injury, prevent sperm from entering the ejaculate even when production is normal.

Other causes include ejaculation issues, immune system problems where the body produces antibodies against its own sperm, and lifestyle factors including smoking, excessive alcohol consumption, and obesity. Environmental exposures to chemicals, radiation, or excessive heat can also impair fertility, as can certain medications and medical treatments, particularly chemotherapy.

It's worth noting that in about 30% of cases, we identify multiple factors contributing to fertility challenges, which is why a comprehensive evaluation is so important.

Genetic Factors

Chromosomal Abnormalities: These account for approximately 6% of infertility cases in men. Klinefelter Syndrome (47,XXY) is the most common, affecting approximately 1 in 500-1,000 newborn males. Men with this condition typically have very low or no sperm production.

Y Chromosome Microdeletions: These occur in about 7-10% of men with severe oligozoospermia and 10-15% of men with azoospermia. The Y chromosome contains critical genes for spermatogenesis, particularly in the azoospermia factor (AZF) regions.

Cystic Fibrosis Gene Mutations: Present in approximately 70-80% of men with congenital bilateral absence of the vas deferens (CBAVD). These men produce sperm but cannot transport it into the ejaculate.

Hormonal Disorders

Hypogonadotrophic Hypogonadism: Results from inadequate stimulation of the testes by FSH and LH. This can be congenital (Kallmann syndrome) or acquired through pituitary tumours, traumatic brain injury, or excessive exercise.

Hyperprolactinemia: Elevated prolactin levels can suppress the hypothalamic-pituitary-gonadal axis, impairing testosterone production and spermatogenesis.

Thyroid Dysfunction: Both hypo- and hyperthyroidism can disrupt the delicate hormonal balance necessary for normal sperm production.

Androgen Insensitivity: Impaired response to testosterone can affect the development and function of the male reproductive system.

Structural Issues

Varicocele: Present in approximately 35-44% of men with primary infertility and 45-81% with secondary infertility (European Association of Urology). Varicoceles cause increased testicular temperature and oxidative stress, impairing sperm production and function.

Ejaculatory Duct Obstruction: Can result from infection, prior surgery, or congenital anomalies, preventing sperm from entering the ejaculate.

Undescended Testes (Cryptorchidism): Men with a history of this condition have higher rates of infertility, even after successful treatment, due to the impact of abnormal testicular positioning on temperature regulation and development.

Testicular Factors

Testicular Trauma: Severe trauma can impair blood supply and cause direct damage to the sperm-producing tissue.

Post-infectious Damage: Mumps orchitis in adulthood can cause significant testicular damage if both testes are affected.

Radiation/Chemotherapy Exposure: Cancer treatments can temporarily or permanently damage sperm production. The impact depends on the specific agents, dosage, and individual factors.

Immunological Factors

Anti-sperm Antibodies: Present in 3-12% of infertile men. These can develop after vasectomy, testicular trauma, infection, or surgery, causing sperm agglutination, reduced motility, and impaired egg penetration.

Lifestyle and Environmental Factors

Heat Exposure: Elevated testicular temperature from saunas, hot tubs, tight clothing, or prolonged sitting can temporarily reduce sperm production.

Toxin Exposure: Pesticides, industrial chemicals, heavy metals, and radiation can damage sperm DNA and reduce production.

Medication Effects: Certain medications including anabolic steroids, some antihypertensives, antipsychotics, and chemotherapy agents can impair fertility.

Substance Use: Tobacco, excessive alcohol, marijuana, and other recreational drugs have dose-dependent negative effects on sperm parameters.

Idiopathic Infertility

Despite comprehensive evaluation, approximately 25-30% of male infertility cases remain unexplained (idiopathic). Current research suggests that many of these cases may be related to:

- Undetected genetic factors
- Epigenetic modifications
- Sperm DNA fragmentation
- Advanced paternal age
- Reactive oxygen species (oxidative stress)
- Environmental exposures

This comprehensive understanding of causal factors guides our diagnostic approach and treatment strategies for each individual.

Explore treatment options

Diagnosis: How We Assess Male Fertility

Diagnosing male fertility issues begins with a thorough assessment. The process starts with a detailed medical history, where I'll discuss your general health, reproductive history, lifestyle factors, and any symptoms you may be experiencing. This conversation often reveals important clues about potential causes of fertility challenges.

A physical examination follows, focusing on the genital area to check for varicoceles, testicular size and consistency, and any structural abnormalities that might affect fertility. This examination is performed respectfully and professionally, with clear explanation throughout.

The cornerstone of male fertility testing is semen analysis, which evaluates key parameters including sperm count, motility, and morphology. If the first result is outside the reference range, I repeat the test to confirm it, ideally about three months later (sooner if no sperm, or very few, are found), as sperm parameters can naturally fluctuate. These tests provide essential information about sperm production and quality.

Depending on your specific situation, we may also conduct hormone testing to check levels of testosterone, FSH, LH, and other hormones that regulate reproductive function. For some men, genetic testing may be appropriate, particularly if we suspect chromosomal abnormalities or genetic causes of infertility.

Ultrasound imaging (e.g. scrotal ultrasound) is often valuable to examine the testes and check for varicoceles or other structural issues. NICE (NG257, recommendation 1.17.6) advises against testing for sperm DNA integrity (fragmentation). Results also depend on the laboratory method used, so there is no single cut-off that applies everywhere.

A proper diagnosis is crucial for developing an effective treatment plan tailored to your specific needs. Throughout this process, I ensure that you understand each test and its significance for your fertility journey.

Need a comprehensive fertility assessment?

Our specialist clinic offers the latest diagnostic techniques.

Understanding Your Semen Analysis

Semen analysis is the most important test for assessing male fertility. It evaluates several key parameters that provide crucial insights into reproductive potential.

Sperm count, or concentration, tells us how many sperm are present per millilitre of semen. Motility assesses the percentage of sperm that are moving and how well they move, which is essential for reaching and fertilising an egg. Morphology examines the shape and structure of sperm, as abnormally shaped sperm may have difficulty fertilising an egg.

The volume of ejaculate is also important, as it affects the total number of sperm delivered. Additionally, we assess the pH and other factors that influence sperm function and survival.

Reference values come from the World Health Organization's laboratory manual, sixth edition (2021): a volume of at least 1.4 ml, a sperm concentration of 16 million per millilitre or more, a total sperm number of at least 39 million per ejaculate, total motility of at least 42%, progressive motility of at least 30%, normal forms of 4% or more, and a pH of at least 7.2. Vitality, where it is measured, is 54% or more live sperm — it is usually checked when motility is low rather than as a routine line on every report. It is important to understand what these figures are: each one is the fifth centile of men whose partners conceived naturally within a year. They are not a pass or a fail. A result slightly below one of them does not mean you cannot conceive, and a result above it does not guarantee you will. Note too that the percentages are not a breakdown of one another — each is calculated on its own distribution, so they are not meant to add up. I always interpret your numbers as a whole, and in the context of you and your partner together.

What the new WHO infertility guideline means for men

In November 2025 the World Health Organization published its first global guideline on preventing, diagnosing and treating infertility. For men it does not overturn how we work — it confirms much of it, and sharpens a few points worth knowing.

Semen analysis stays central, but we test more sensibly. Where the guideline refines earlier advice is on repeat testing: if your first analysis is entirely normal, a routine repeat usually is not needed. If it is abnormal, a second test is valuable — but it is best taken no sooner than eleven weeks later, and ideally about three months later, so that it reflects a fresh cycle of sperm production rather than a short-term dip. If no sperm, or very few, are found, the repeat is arranged sooner than eleven weeks.

Varicocele repair earns cautious support. For men with a varicocele that can be felt on examination, difficulty conceiving and abnormal semen results, the guideline suggests treatment rather than simply waiting — and, where repair is chosen, a microsurgical approach in preference to others.

Stopping smoking is the clearest win. This was among the guideline’s strongest recommendations: if you smoke and are trying to conceive, quitting is one of the most reliable things you can do for your sperm and your general health.

On supplements, an honest answer. The WHO reviewed antioxidant supplements and concluded the evidence is not strong enough to recommend either for or against them. Good nutrition matters, but antioxidants are not a proven treatment and are never a substitute for finding and addressing the underlying cause.

Two further positions have since been published and they do not agree with each other, so it is worth being precise. The Global Andrology Forum's 2026 antioxidant guideline allows that antioxidants may be considered where sperm DNA fragmentation is high and the rest of the semen analysis is normal — but grades that statement among its weaker ones. NICE, in NG257 recommendation 1.24.6, is unambiguous: do not offer supplements, antioxidants or medical treatments to improve sperm DNA integrity. I follow NICE, for reasons I have set out in full on the sperm DNA fragmentation page rather than repeating them here.

One honest caveat: this first guideline deliberately does not yet cover several areas central to complex male infertility — among them azoospermia, surgical sperm retrieval and advanced sperm-DNA testing. Those remain guided by specialist urological and andrological evidence, which is what the rest of this page sets out.

Understanding these values helps us determine if male factor infertility is present and guides our treatment approach. I always take time to explain your results in context, as values slightly below these references may still be compatible with natural conception, while values significantly below these thresholds may suggest the need for medical intervention.

The Semen Analysis Process

Sample Collection

Proper sample collection is crucial for accurate results:

- Abstinence Period: 2-7 days of sexual abstinence is recommended before sample collection, as the WHO laboratory manual (sixth edition) advises. Shorter or longer periods may affect results.
- Collection Method: Masturbation into a clean, sterile container is preferred. Special non-toxic condoms can be used in certain circumstances.
- Timing: The sample should be analysed within 1 hour of collection to prevent degradation.
- Temperature: The sample should be kept at body temperature (not below 20°C or above 37°C) during transport.
- Complete Collection: It's important to collect the entire ejaculate, as the first portion contains the highest concentration of sperm.

Standard Parameters and Their Clinical Significance

1. Volume (1.4 ml or more):

- Low Volume Causes: Incomplete collection, ejaculatory duct obstruction, congenital absence of vas deferens, retrograde ejaculation, or hypogonadism.
- Clinical Significance: Low volume may indicate structural issues or hormonal deficiencies.

1. pH (7.2 or higher):

- Clinical Significance: Low pH may suggest obstructive issues or abnormalities of the accessory glands (seminal vesicles, prostate).

1. Sperm Concentration (16 million/ml or more):

- Terminology:
- Azoospermia: No sperm in ejaculate
- Cryptozoospermia: Very few sperm found only after centrifugation
- Severe Oligozoospermia: <5 million/ml
- Oligozoospermia: <16 million/ml (below the WHO lower reference limit)
- Clinical Significance: Low counts may indicate testicular failure, hormonal issues, genetic factors, or obstructive problems.

1. Total Sperm Number (39 million or more):

- Clinical Significance: This is calculated by multiplying concentration by volume and provides a more accurate assessment of total sperm output.

1. Motility (42% or more total motile; 30% or more progressively motile):

- Terminology:
- Asthenozoospermia: Reduced motility
- Progressive Motility: Sperm moving actively, either linearly or in a large circle
- Non-progressive Motility: All other patterns of movement
- Immotility: No movement
- Clinical Significance: Poor motility may result from testicular dysfunction, varicocele, infection, anti-sperm antibodies, or oxidative stress.

1. Morphology (4% or more normal forms):

- Terminology: Teratozoospermia: Reduced percentage of normal forms
- Assessment: Strict criteria (Kruger) examining head, midpiece, and tail
- Clinical Significance: Abnormal morphology can indicate testicular damage, varicocele, or genetic factors.

1. Vitality (54% or more live):

- Assessment: Dye exclusion tests (eosin-nigrosin)
- Clinical Significance: Important when motility is low to distinguish between dead sperm and live but immotile sperm.

1. Leukocytes (less than 1 million/ml):

- Clinical Significance: Elevated white blood cell count (leukocytospermia) suggests genital tract infection or inflammation.

Advanced Sperm Function Tests

In specific cases, additional tests may provide valuable information:

1. Sperm DNA Fragmentation:

- Methods: Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), Sperm Chromatin Structure Assay (SCSA), Comet Assay
- Clinical Significance: Each laboratory method has its own thresholds, so no single figure separates normal from raised. NICE (NG257) advises against testing for sperm DNA fragmentation (recommendation 1.17.6) and against supplements, antioxidants or medical treatments to improve it (recommendation 1.24.6).
- Where it is discussed: Recurrent miscarriage or repeated failed assisted reproduction. Specialist opinion on its value differs, and NICE does not recommend it.

1. Reactive Oxygen Species (ROS) Testing:

- Clinical Significance: Excessive ROS causes oxidative stress, damaging sperm membranes and DNA.
- Indications: Unexplained infertility, poor sperm parameters without obvious cause

1. Halo Test (Sperm Chromatin Dispersion):

- Assessment: Evaluates chromatin integrity and DNA fragmentation
- Clinical Significance: Another way of measuring DNA fragmentation; the same NICE advice applies.

1. Computer-Assisted Semen Analysis (CASA):

- Benefits: Provides detailed, objective assessment of motility patterns and kinematics
- Parameters Measured: Curvilinear velocity, straight-line velocity, linearity, amplitude of lateral head displacement

1. Anti-Sperm Antibody Testing:

- Methods: Mixed antiglobulin reaction (MAR test), immunobead test
- Clinical Significance: Antibodies coating >50% of sperm may impair fertility
- Indications: History of testicular trauma, surgery, infection, or unexplained infertility

Interpreting Results

It's important to recognise several factors when interpreting semen analysis:

1. Biological Variation: Sperm parameters naturally fluctuate in the same individual. If a first result is outside the reference range, a second sample, ideally about three months later and no sooner than eleven weeks, is needed to confirm it.
1. Laboratory Variation: Quality control is essential. Seek analysis from specialised andrology laboratories adhering to WHO guidelines.
1. Predictive Value: Semen parameters correlate with fertility prospects but have limitations. Men with abnormal parameters can achieve pregnancy, while men with normal parameters may experience infertility due to functional defects.
1. Combined Parameters: The total motile sperm count (concentration × volume × percentage motile) offers a more comprehensive assessment than individual parameters.
1. Threshold Values: Rather than absolute cutoffs, the reference limits represent statistical derivations from fertile populations. Values near the threshold require careful interpretation.
1. Recent Factors: Fever, medication changes, or significant stress within 2-3 months before testing can temporarily affect results.

Understanding these nuances allows for more accurate diagnosis and appropriate treatment planning.

Treatment Options for Male Infertility

Treatment approaches depend on the specific cause of infertility. As your specialist, I'll develop a personalised plan that addresses your unique needs and circumstances.

Lifestyle Modifications

Simple changes can significantly improve fertility for many men. A healthy diet rich in antioxidants supports sperm health, with particular benefits from foods like fruits, vegetables, nuts, and fish. Regular moderate exercise improves hormone balance and overall reproductive health, though excessive training can actually impair fertility.

Stress reduction techniques such as mindfulness, meditation, or even regular leisure activities can help counteract the negative effects of stress on sperm production. Adequate sleep is also essential, as sleep disruption can affect hormone levels that regulate fertility.

For many men, avoiding tobacco, limiting alcohol consumption, and abstaining from recreational drugs can substantially improve sperm parameters. Managing weight is important too, as both obesity and being significantly underweight can disrupt hormone balance and sperm production.

I also recommend limiting heat exposure to the testicles by avoiding hot baths, saunas, and tight-fitting underwear for extended periods. These simple lifestyle adjustments often yield impressive improvements in sperm parameters within three to six months.

Medical Treatments

When lifestyle changes aren't enough, various medications may help address the underlying causes of infertility.

Hormone therapy can be effective for men with endocrine imbalances, such as hypogonadotrophic hypogonadism or elevated prolactin levels. These treatments aim to restore the proper hormonal environment for sperm production. For men with reproductive tract infections, appropriate antibiotics can resolve inflammation that may be impairing fertility.

Medicines to improve sperm production are more limited than they are often presented. For men with impaired semen results who do not have hypogonadotrophic hypogonadism, NICE advises considering anti-oestrogen drugs such as clomifene only as part of a clinical trial, and it advises against supplements, antioxidants or medical treatments to improve sperm DNA integrity.

For men experiencing erectile or ejaculatory dysfunction that impacts their ability to conceive, medications addressing these specific challenges can be valuable components of fertility treatment.

Surgical Interventions

Surgical procedures can address specific structural issues that contribute to infertility. Varicocele repair, preferably using a microsurgical approach, can improve sperm parameters and fertility rates in men with significant varicoceles. For men who have previously undergone vasectomy, vasectomy reversal is possible, but it is not always successful and should not be relied upon. The chance of success depends on several factors, including how long ago the vasectomy was done.

Transurethral resection of ejaculatory duct obstruction may benefit men whose sperm transport is blocked at this level. For men with no sperm in their ejaculate, surgical sperm retrieval techniques allow us to obtain sperm directly from the reproductive tract for use with assisted reproductive technologies.

Comprehensive Guide to Surgical Sperm Retrieval

Surgical sperm retrieval (SSR) techniques allow us to obtain sperm directly from the reproductive tract when sperm is not present in the ejaculate (azoospermia) or when ejaculation is not possible. These procedures have revolutionised the treatment of severe male factor infertility, allowing men who previously had no options to father genetically related children.

Types of Surgical Sperm Retrieval

1. Percutaneous Epididymal Sperm Aspiration (PESA)

- Technique: Using a fine needle attached to a syringe, sperm is aspirated directly from the epididymis under local anaesthesia.
- Ideal for: Men with obstructive azoospermia (normal sperm production but blockage in the sperm transport system) such as: Congenital absence of vas deferens, Failed vasectomy reversal, Post-infection scarring.
- Advantages: Minimally invasive, Can be performed under local anaesthesia, Quick recovery.
- Limitations: May not retrieve enough sperm for cryopreservation, Not suitable for non-obstructive azoospermia, Risk of haematoma or fibrosis with repeated procedures.

1. Microsurgical Epididymal Sperm Aspiration (MESA)

- Technique: Open surgical procedure using an operating microscope to precisely identify and aspirate fluid from the epididymal tubules.
- Ideal for: Obstructive azoospermia when maximum sperm yield is desired.
- Advantages: Higher sperm yield than PESA, Usually retrieves enough sperm for freezing, Precise identification of epididymal tubules.
- Limitations: More invasive, Requires microsurgical expertise, Longer recovery time, Higher cost.

1. Testicular Sperm Aspiration (TESA)

- Technique: Fine-needle aspiration of testicular tissue using a needle and syringe.
- Ideal for: Obstructive azoospermia when epididymal approaches fail, Selected cases of non-obstructive azoospermia.
- Advantages: Relatively simple procedure, Can be performed under local anaesthesia, Minimal recovery time.
- Limitations: Lower sperm yield, Higher risk of retrieving immature sperm, Not ideal for severe testicular failure.

1. Conventional Testicular Sperm Extraction (TESE)

- Technique: Small incision in the testis to extract seminiferous tubules for processing and sperm extraction.
- Ideal for: Non-obstructive azoospermia with: Maturation arrest, Hypospermatogenesis, Focal areas of spermatogenesis.
- Advantages: Higher sperm yield than TESA, Good option for moderate testicular failure.
- Limitations: More invasive than aspiration techniques, Potential for testicular damage, Suboptimal for severe testicular failure.

1. Microdissection Testicular Sperm Extraction (MicroTESE)

- Technique: Advanced microsurgical procedure using high-powered magnification to identify and extract specific seminiferous tubules likely to contain sperm.
- Ideal for: Severe non-obstructive azoospermia, including: Sertoli cell-only syndrome, Severe hypospermatogenesis, Failed previous TESE, Klinefelter syndrome, Y-chromosome microdeletions (except AZFa and complete AZFb).
- Advantages: Highest sperm retrieval rates for severe cases (40-60% success even in challenging cases), Minimises testicular damage, Preserves testicular blood supply, Maximises sperm yield.
- Limitations: Requires specialised microsurgical expertise, Longer operating time, Higher cost, Limited availability in some regions.

The MicroTESE Procedure: A Closer Look

As a specialist in microsurgical techniques, I consider MicroTESE the gold standard for men with non-obstructive azoospermia. This sophisticated procedure involves:

1. Preparation: General anaesthesia, Midline scrotal incision, Delivery of the testis.
1. Equatorial Incision: The testis is opened along its equator under microscopic guidance. This approach provides a comprehensive view of the testicular architecture.
1. Microdissection (20-25x magnification): Careful examination of seminiferous tubules, Identification of larger, more opaque tubules (more likely to contain sperm), Selective extraction of promising tubules, Preservation of testicular blood supply, Immediate laboratory examination of extracted tissue.
1. Tissue Processing: Mechanical and enzymatic processing of extracted tissue, Identification of sperm under high-powered microscopy, Immediate use for ICSI or cryopreservation.
1. Closure: Meticulous layered closure of the tunica albuginea, Scrotal closure with absorbable sutures.

Factors Affecting Sperm Retrieval Success

1. Testicular Histology: Hypospermatogenesis: 73-100% success rate; Maturation arrest: 27-86% success rate; Sertoli cell-only syndrome: 27-50% success rate (with MicroTESE).
1. Hormonal Parameters: FSH levels: Not an absolute predictor, but very high levels may indicate lower chances; Testosterone levels: Higher preoperative levels correlate with better outcomes; Inhibin B: Higher levels generally predict better sperm retrieval rates.
1. Genetic Factors: Klinefelter syndrome: 40-70% success with MicroTESE; Y-chromosome microdeletions: Depends on the region affected (AZFc: 50-70% success; AZFa or complete AZFb: very poor prognosis).
1. Prior Treatments: Hormonal treatment before surgery is under study; NICE advises considering anti-oestrogen therapy only within a clinical trial for men without hypogonadotrophic hypogonadism.
1. Surgical Technique: MicroTESE consistently outperforms conventional TESE in difficult cases; Surgeon experience significantly impacts success rates.

Sperm Cryopreservation

Whenever possible, we recommend freezing extra sperm obtained during SSR procedures for future use. This approach:

- Avoids the need for repeated surgical procedures
- Provides psychological reassurance
- Allows for multiple IVF/ICSI cycles from a single retrieval
- Enables more flexible timing for the female partner's IVF cycle

Postoperative Care and Considerations

1. Physical Recovery: Rest for 24-48 hours; Ice packs to reduce swelling; Supportive underwear for 1-2 weeks; Avoidance of strenuous activity for 1-2 weeks; Sexual abstinence for 1-2 weeks.
1. Potential Complications: Haematoma (1-5%); Infection (rare); Testicular atrophy (rare with microsurgical techniques); Hypogonadism (temporary decline in testosterone possible).
1. Follow-up: Wound check at 1-2 weeks; Hormonal assessment at 3-6 months (especially after extensive procedures); Ultrasound may be performed to evaluate testicular integrity.
1. Long-term Considerations: Most men maintain normal testicular function after SSR; Repeated procedures may have cumulative effects on testicular function; Regular hormonal monitoring may be recommended for selected patients.

The choice of surgical sperm retrieval technique is individualised based on the underlying diagnosis, previous history, and the couple's overall fertility treatment plan. As a microsurgical specialist, I can help you navigate these options and determine the most appropriate approach for your specific situation.

Considering surgical treatment?

Book a consultation to discuss which procedure might be right for you.

Assisted Reproductive Technologies (ART)

For many couples with male factor infertility, assisted reproduction provides the path to parenthood. The appropriate technique depends on the severity of the male factor and other aspects of the couple's fertility.

Intrauterine insemination (IUI) may be suitable for mild male factor infertility. This procedure involves placing washed and concentrated sperm directly into the uterus around the time of ovulation, bypassing the cervix and reducing the distance sperm must travel.

In vitro fertilisation (IVF) is often recommended for moderate cases of male factor infertility. This process involves stimulating the ovaries to produce multiple eggs, retrieving those eggs, and combining them with sperm in the laboratory. The resulting embryos are then transferred to the uterus.

For severe male factor infertility, intracytoplasmic sperm injection (ICSI) is typically the treatment of choice. In this procedure, a single sperm is directly injected into each egg, overcoming issues with sperm number, motility, or ability to penetrate the egg.

When there is no sperm in the ejaculate, surgical sperm retrieval combined with ICSI offers the possibility of genetic fatherhood. Sperm obtained directly from the testes or epididymis can be used to fertilise eggs through ICSI, creating a pathway to parenthood even in the most challenging cases.

Assisted Reproductive Technologies: A Comprehensive Overview

Assisted reproductive technologies have transformed the landscape of male infertility treatment, offering hope to men with even the most severe sperm abnormalities. Understanding these options in detail can help you navigate your fertility journey more confidently.

Intrauterine Insemination (IUI)

The Process:

1. Sperm washing and concentration to select the most viable sperm
1. Direct placement of prepared sperm into the uterus via a thin catheter
1. Timed to coincide with ovulation (natural or stimulated)

Optimal Candidates: Mild to moderate oligozoospermia (5-15 million/ml); Good sperm motility (>30% progressive); Normal morphology (>4%); At least 1-3 million total motile sperm after processing; No female factor infertility.

Success Factors: Female partner age (significantly lower success rates >35 years); Duration of infertility (<3 years more favourable); Total motile sperm count after processing; Number of follicles (in stimulated cycles).

Success Rates: 5-15% per cycle for male factor infertility; Cumulative pregnancy rates of 20-30% after 3-4 cycles; Beyond 4-6 unsuccessful cycles, progression to IVF/ICSI is usually recommended.

Advantages: Less invasive than IVF/ICSI; Lower cost; Reduced medication requirements; Can be performed during natural cycles.

Limitations: Not suitable for severe male factor infertility; Lower success rates compared to IVF/ICSI; Limited effectiveness with female factor infertility.

In Vitro Fertilisation (IVF)

The Process:

1. Ovarian stimulation and monitoring in the female partner
1. Egg retrieval under sedation
1. Sperm collection and preparation
1. Combining eggs and prepared sperm in laboratory conditions
1. Embryo culture for 3-5 days
1. Embryo transfer to the uterus
1. Luteal phase support and pregnancy testing

Optimal Candidates for Standard IVF (without ICSI): Moderate oligozoospermia (>3-5 million/ml); Reasonable motility (>25% progressive); At least 100,000 motile sperm after preparation; Cases where fertilisation capability needs to be assessed.

Success Factors: Female partner age (primary determinant); Sperm parameters (quantity and quality); Embryo quality; Endometrial receptivity; Number of previous IVF attempts; Response to ovarian stimulation.

Success Rates: Overall live birth rates: 20-40% per cycle; For male factor infertility: Similar to general IVF rates if sperm parameters are adequate; May have lower fertilisation rates in severe male factor cases without ICSI.

Advantages: Higher success rates than IUI; Allows assessment of fertilisation capability; Provides embryos for potential freezing and future use; Enables genetic testing of embryos if required.

Limitations: More invasive and costly than IUI; Requires significant medication for the female partner; Risk of ovarian hyperstimulation syndrome; Potential for failed fertilisation in male factor cases.

Intracytoplasmic Sperm Injection (ICSI)

The Process:

1. Same steps as IVF for the female partner
1. Individual sperm selection under high magnification
1. Direct injection of a single sperm into each mature egg
1. Subsequent embryo culture, transfer, and monitoring as per IVF

Optimal Candidates: Severe oligozoospermia (<5 million/ml); Poor motility (<25% progressive); Abnormal morphology (<4% normal forms); Previous fertilisation failure with standard IVF; Surgical sperm retrieval cases; Advanced maternal age where fertilisation efficiency is crucial; Preimplantation genetic testing planned.

Success Factors: Similar to IVF, predominantly influenced by female age; Quality of available sperm (even with severe abnormalities, sperm selected for ICSI can yield good results); Source of sperm (ejaculated typically better than surgically retrieved); Laboratory expertise in sperm selection and microinjection.

Success Rates: Fertilisation rates: 60-80% of mature eggs; Clinical pregnancy rates: Comparable to standard IVF (30-50% per transfer); Live birth rates: 20-40% per cycle, varying by age and clinic.

Advantages: Overcomes severe male factor infertility; Requires only a single sperm per egg; Eliminates the need for sperm to penetrate the egg naturally; Allows genetic fatherhood for men with minimal sperm production.

Limitations: Higher cost than standard IVF; Theoretical risk of transmitting genetic abnormalities (natural selection is bypassed); Potential for slight increase in certain congenital abnormalities (though absolute risk remains low); Requires specialised laboratory expertise.

Advanced Sperm Selection Techniques

For cases of severe male factor infertility, clinics may offer advanced sperm selection methods. These are treatment add-ons, often at extra cost. The HFEA rates the evidence for each, and most patients do well with standard ICSI without them:

1. Physiological Intracytoplasmic Sperm Injection (PICSI): Uses hyaluronic acid binding to select mature sperm. The HFEA rates PICSI black for patients having ICSI for male factor infertility: moderate to high quality evidence shows it has no effect on the chance of having a baby.
1. Intracytoplasmic Morphologically Selected Sperm Injection (IMSI): Uses high-power microscopy to select sperm by the appearance of the head. The HFEA rates IMSI grey: there is not enough good-quality evidence to say whether it improves the chance of having a baby.
1. Microfluidic Sperm Sorting: Uses sperm's natural ability to swim against a fluid current to select the most progressively motile sperm. Whether this improves the chance of having a baby has not been established.
1. Magnetic-Activated Cell Sorting (MACS): Separates apoptotic (programmed for cell death) from healthy sperm. The HFEA rates MACS with ICSI grey for male factor infertility: there is not enough good-quality evidence that it improves the chance of having a baby.

Surgical Sperm Retrieval with ICSI

For men with azoospermia (no sperm in the ejaculate), the combination of surgical sperm retrieval and ICSI has created a pathway to biological fatherhood:

Success Factors: Type of azoospermia (obstructive vs. non-obstructive); Surgical technique used (MicroTESE providing the highest retrieval rates for non-obstructive cases); Underlying genetic factors; Female partner's age and ovarian reserve; Laboratory expertise in handling surgically retrieved sperm.

Success Rates: Obstructive azoospermia: Similar to ICSI with ejaculated sperm (30-50% clinical pregnancy rate per cycle); Non-obstructive azoospermia: Slightly lower (20-40% clinical pregnancy rate when sperm is found); Cumulative live birth rates can reach 60-70% after multiple cycles if sperm is successfully retrieved.

Special Considerations: Sperm cryopreservation is strongly recommended when possible; Pre-procedure genetic counselling for cases of non-obstructive azoospermia; Coordination between surgical retrieval and egg collection is critical; Laboratory processing of testicular tissue requires specialised expertise.

Decision-Making: Choosing the Right ART Approach

The decision pathway typically follows this progression:

1. For mild male factor with good total motile count: Consider IUI first (3-4 cycles)
1. For moderate male factor or failed IUI: Progress to IVF
1. For severe male factor or poor fertilisation with standard IVF: ICSI is the treatment of choice
1. For azoospermia: Surgical sperm retrieval with ICSI

Factors influencing the decision include: Severity of sperm abnormalities; Female partner factors (age, ovarian reserve, other fertility issues); Previous treatment outcomes; Time constraints; Financial considerations; Couple's preferences after informed counselling.

By understanding these options in detail, you can have more productive discussions with your fertility specialist and make informed decisions about your treatment journey.

Discuss Success Rates

Emotional Support and Counselling

Infertility can be emotionally challenging, often described by patients as one of the most stressful experiences of their lives. The journey can bring feelings of inadequacy, guilt, anxiety, and grief that deserve attention alongside medical treatment.

I strongly recommend counselling with specialists in fertility-related emotional support. These professionals understand the unique challenges faced by individuals and couples dealing with infertility and can provide valuable coping strategies and perspective.

Support groups connecting you with others experiencing similar challenges can reduce feelings of isolation and provide practical insights from those who truly understand your journey. The shared experience can be incredibly validating and empowering.

Open communication with your partner is essential, as fertility challenges can strain even the strongest relationships. Learning to express feelings, needs, and concerns constructively helps navigate this journey together rather than allowing it to drive you apart.

Self-care practices to manage stress and anxiety should be incorporated into your routine. Whether through physical activity, mindfulness meditation, creative expression, or time in nature, finding ways to nurture your wellbeing supports both emotional health and fertility.

Throughout your treatment, I and my team remain committed to supporting your emotional wellbeing alongside your physical health, recognising that these aspects are deeply interconnected.

Understanding and Managing the Emotional Journey

Male factor infertility can trigger complex emotional responses that often go unaddressed in clinical settings. In my practice, I recognise that treating the whole person—not just the medical condition—is essential for true healing.

Common Emotional Responses

Shame and Stigma

Many men report profound feelings of shame connected to infertility. This stems from:

- Cultural associations between fertility and masculinity
- Misconceptions about male virility and reproductive capability
- Limited social discourse around male reproductive issues
- Internalised expectations about the male role in reproduction

Research indicates that men with infertility experience stigmatisation differently than women, often suffering in silence due to fewer social support systems and normalised outlets for expression.

Grief and Loss

The experience of infertility involves multiple losses:

- Loss of the expected reproductive outcome
- Loss of control over family planning
- Loss of a genetic connection with potential children
- Loss of the shared biological experience with a partner
- Loss of the expected life trajectory

This grief often goes unrecognised as "disenfranchised grief" since it doesn't involve a tangible, socially acknowledged loss.

Relationship Strain

Infertility can significantly impact intimate relationships:

- Communication difficulties around sensitive topics
- Different coping mechanisms between partners
- Sexual dysfunction secondary to performance pressure
- Imbalance in treatment burden (typically heavier on female partners)
- Financial stressors related to treatment

Studies show that while infertility can create strain, couples who navigate it together often report strengthened relationships long-term.

Anxiety and Depression

Research indicates higher rates of both anxiety and depression among men with infertility:

- 15-20% experience clinical depression during infertility treatment
- 25-30% report significant anxiety symptoms
- These rates increase with treatment duration and failures

These mental health impacts can create a negative cycle, as stress and depression may further impact sperm parameters.

Effective Coping Strategies

Based on both clinical experience and research, these approaches have proven beneficial:

Professional Support

- Specialised Counselling: Therapists with specific training in reproductive issues understand the unique challenges of infertility.
- Cognitive-Behavioural Therapy (CBT): Has shown particular efficacy in addressing negative thought patterns common in infertility.
- Mind-Body Programmes: Structured programmes combining education, support, and stress management techniques show positive outcomes.

Communication Strategies

- Scheduled "Fertility Discussions": Setting aside specific times to discuss treatment helps contain the impact on the relationship.
- Active Listening Practice: Learning to validate each other's experiences without problem-solving.
- Shared Decision-Making Frameworks: Structured approaches to weighing treatment options together.

Community Connection

- Male-Specific Support Groups: Environments where men can share experiences with others who understand.
- Online Communities: Anonymous platforms that allow for expression without face-to-face vulnerability.
- Mentor Systems: Connection with men who have successfully navigated infertility.

Reframing Approaches

- Narrative Therapy: Reconstructing the story of infertility from one of "failure" to one of resilience.
- Meaning-Focused Coping: Finding purpose in the challenge, whether through advocacy, supporting others, or personal growth.
- Post-traumatic Growth Perspective: Recognising how navigating infertility can develop profound personal strengths.

Supporting the Male Partner Through Treatment

Specific support strategies for different treatment phases include:

Diagnostic Phase: Normalise emotional responses to initial diagnosis; Provide information in manageable segments; Involve men directly in all consultations; Create space for questions and processing.

Treatment Decision-Making: Present options with balanced information about each approach; Acknowledge the emotional as well as financial costs; Discuss boundaries and limits before beginning; Create structured decision tools when helpful.

During Active Treatment: Provide clear role expectations for male partners; Offer specific support during sperm collection (privacy, reduced pressure); Include check-ins about emotional well-being at each appointment; Connect to support resources proactively, not only when crisis emerges.

After Failed Treatments: Acknowledge the grief process for both partners; Provide space to process before discussing next steps; Offer specific support for the male partner, who often assumes a "supporting role"; Discuss relationship maintenance strategies during recovery.

Moving Forward: Support in exploring alternative family-building options; Assistance in determining when to stop treatment; Guidance on finding closure and meaning; Resources for long-term relationship health.

By addressing these emotional aspects alongside medical treatment, we create a truly comprehensive approach to male infertility care.

Need emotional support during your fertility journey?

Our team includes counsellors specialising in male fertility issues.

Learn About Counselling Options

Myths vs. Facts About Male Fertility

Many misconceptions exist about male fertility. Let's address some common myths with evidence-based facts to help you better understand this important aspect of men's health.

Fact: Male factors contribute to infertility in approximately 50% of cases. In about 30% of couples, the issue is exclusively male-related, with another 20% having combined male and female factors. Male reproductive health deserves equal attention when addressing fertility challenges.

Fact: A man's build, musculature, or other physical characteristics have no reliable correlation with fertility. I've treated professional athletes with severe fertility issues and men with less traditionally "masculine" builds who have excellent sperm parameters. Fertility cannot be judged by appearance.

Fact: While men continue producing sperm throughout life, sperm quality declines with age. Research shows decreased fertility and increased DNA fragmentation in sperm from men over 40. Advanced paternal age also correlates with increased risks of miscarriage and certain conditions in offspring. Male fertility does have an age factor, even if less dramatic than the female biological clock.

Fact: While excessive heat can affect sperm production, modern research suggests the difference between underwear types is minimal for most men. Temperature effects are temporary and reversible. Focus on more substantial lifestyle factors like smoking cessation and weight management for meaningful fertility improvements.

Fact: Antioxidants and supplements are not a cure for male infertility, and they are not a proven treatment. The WHO found the evidence not strong enough to recommend either for or against them, and NICE advises against offering supplements or antioxidants to improve sperm DNA integrity. Always tell your doctor about any supplements you take, as some may interfere with fertility.

Frequently Asked Questions

Generally, I recommend seeking evaluation if you haven't conceived after 12 months of regular, unprotected intercourse. However, you should seek help sooner (after 6 months) if:

- The female partner is over 35 years old
- You have known risk factors for infertility (prior surgeries, undescended testicles, etc.)
- There are issues with sexual function that may impact conception
- You have a pre-existing condition that could affect fertility

Early assessment can provide peace of mind and allow for timely intervention if needed.

Yes, lifestyle modifications can significantly impact sperm parameters in many men. The research is particularly strong for:

- Smoking cessation (improvements seen within 3 months)
- Moderate alcohol reduction
- Weight management (both obesity and being significantly underweight affect fertility)
- Regular moderate exercise (though excessive endurance training may be counterproductive)
- Stress management

In my clinical experience, I've seen remarkable improvements in sperm parameters after focused lifestyle interventions. One patient increased his sperm count from 8 million/ml to 28 million/ml after six months of lifestyle changes including weight loss, smoking cessation, and stress reduction techniques.

Remember that sperm production takes approximately 2-3 months, so allow time for changes to show results.

Your GP can initiate the preliminary evaluation with basic hormone testing and potentially a semen analysis referral. However, for comprehensive male fertility assessment and specialised treatments, referral to a urologist specialising in andrology (male reproductive medicine) is recommended.

The advantages of specialist care include:

- Expertise in interpreting semen analyses
- Experience with advanced diagnostic testing
- Knowledge of the latest treatment approaches
- Surgical skills for procedures like varicocele repair or sperm retrieval
- Coordination with reproductive endocrinologists for couples requiring assisted reproduction

I work closely with GPs and always welcome their initial workup, but the complexity of male fertility often benefits from specialist input.

No, ICSI (Intracytoplasmic Sperm Injection) is not always necessary for male factor infertility. The decision depends on the severity of the sperm abnormalities:

- For mild to moderate oligozoospermia (low sperm count), standard IVF may achieve fertilisation
- For severe oligozoospermia, poor motility, or abnormal morphology, ICSI is typically recommended
- When using surgically retrieved sperm, ICSI is virtually always required

The decision should be made in consultation with your fertility specialist, considering your specific sperm parameters and the fertility clinic's experience and success rates with different approaches.

In some cases, a "split" approach might be used, where some eggs undergo standard IVF and others ICSI, to assess fertilisation potential.

Surgical sperm retrieval success rates vary significantly based on the type of azoospermia (no sperm in the ejaculate) and the retrieval technique used:

For obstructive azoospermia (where sperm production is normal but there's a blockage):

- Success rates are excellent, with sperm retrieval possible in 90-100% of cases using PESA, MESA, or TESE

For non-obstructive azoospermia (where sperm production is impaired):

- Conventional TESE: 30-50% success rate
- MicroTESE (microsurgical testicular sperm extraction): 40-60% success rate, reaching up to 70% in specialised centres

Factors affecting success include:

- The specific cause of azoospermia
- Previous treatments and testicular history
- Hormonal parameters (FSH, testosterone levels)
- The surgeon's experience, particularly with microsurgical techniques
- The laboratory's expertise in identifying and processing sperm from testicular tissue

Insurance coverage for male fertility treatment in the UK varies significantly:

- The NHS funds some fertility treatment, but eligibility criteria are set locally by integrated care boards (ICBs), so they vary across England
- Basic diagnostic testing is usually covered
- Treatment coverage depends on specific circumstances and local funding policies
- Private health insurance typically covers diagnosis but may exclude fertility treatments
- Surgical procedures like varicocele repair may be covered if deemed medically necessary
- Assisted reproductive technologies (IVF/ICSI) are typically not covered by private insurance

I recommend:

1. Check your specific policy details
1. Inquire about NHS eligibility criteria in your area
1. Discuss potential coverage with your insurer before beginning treatment
1. Consider self-funding options and payment plans at fertility clinics
1. Explore charitable organisations that provide grants for fertility treatment

My practice staff can provide guidance on insurance coding and documentation to maximise your coverage potential. (Refer to Contact Us for specific enquiries about your insurance)

About Our Male Fertility Clinic

As a consultant urological surgeon specialising in male fertility, I lead a dedicated team committed to providing exceptional care. Our clinic offers comprehensive diagnostics including advanced semen analysis and genetic testing, enabling us to accurately identify the causes of fertility challenges.

We provide cutting-edge treatments ranging from medical therapies to microsurgical techniques, always staying at the forefront of reproductive medicine. Our approach emphasises coordinated care with gynaecologists and fertility specialists, ensuring that all aspects of a couple's fertility are addressed cohesively.

Throughout your journey with us, we prioritise emotional support at every step. We understand that fertility challenges affect not just your physical health but your emotional wellbeing and relationships too. Our counsellors can provide valuable support as you navigate this path.

Everything we do is grounded in an evidence-based approach using the latest research and technologies. We regularly participate in international conferences and research initiatives to ensure our patients benefit from the most current advances in the field.

I remember clearly why I chose to specialise in male fertility. During my training, I met a young couple who had been told they would never have biological children due to the husband's azoospermia. After thorough evaluation and a successful microsurgical sperm retrieval procedure, they welcomed their daughter the following year. The profound impact of helping create families drives my passion for this field every day.

Our Philosophy and Methodology

At our clinic, we've developed a comprehensive approach to male fertility that combines medical expertise with compassionate care:

Patient-Centred Philosophy

Our treatment approach revolves around these core principles:

1. Personalised Care: We recognise that each man's fertility journey is unique. We tailor our diagnostic and treatment approaches to your specific medical situation, personal preferences, and goals.
1. Comprehensive Assessment: Rather than focusing solely on semen parameters, we evaluate the entire reproductive system, hormonal balance, genetic factors, and lifestyle components that may impact fertility.
1. Evidence-Based Medicine: Our recommendations are grounded in rigorous scientific research and clinical evidence. We continuously update our practices based on emerging research.
1. Minimally Invasive Approach: Whenever possible, we start with the least invasive effective interventions, progressing to more advanced treatments only when necessary.
1. Technological Integration: We use state-of-the-art diagnostic tools and treatment technologies, including high-powered surgical microscopes, advanced sperm function testing, and specialised laboratory techniques.
1. Collaborative Care: We work closely with reproductive endocrinologists, embryologists, nutritionists, and mental health professionals to provide truly comprehensive fertility support.

Our Treatment Pathway

We've developed a systematic approach to assessment and treatment:

1. Initial Consultation

- Detailed medical and reproductive history
- Review of previous fertility testing and treatments
- Physical examination focusing on reproductive system
- Discussion of fertility goals and timeline
- Initial education about male fertility factors

2. Comprehensive Diagnostic Phase

- Standard and advanced semen analysis
- Hormonal profiling (testosterone, FSH, LH, prolactin, estradiol)
- Genetic testing when indicated (karyotype, Y-chromosome microdeletions, cystic fibrosis mutations)
- Further tests where they are clinically indicated
- Ultrasound imaging of testes, epididymis, and prostate
- Testicular mapping in select cases of azoospermia

3. Treatment Planning Consultation

- Detailed review of all test results
- Diagnosis and explanation of fertility issues
- Presentation of all suitable treatment options
- Discussion of success rates, risks, and benefits
- Development of a personalised treatment plan
- Coordination with female partner's fertility evaluation when appropriate

4. Treatment Implementation

Depending on diagnosis, treatments may include:

- Monitored lifestyle modification programme
- Medical therapy for hormonal optimisation
- Specialised treatment for ejaculatory dysfunction
- Microsurgical varicocele repair
- Surgical sperm retrieval techniques (e.g., MicroTESE)
- Coordination with fertility clinics for assisted reproduction (IUI, IVF, ICSI)

5. Follow-up and Monitoring

- Scheduled follow-up consultations
- Repeat semen analysis to assess treatment response
- Hormonal monitoring when relevant
- Adjustment of treatment plan as needed
- Ongoing support throughout treatment journey

6. Long-term Care

- Fertility preservation counselling when appropriate
- General men's health optimisation
- Support for family planning after successful treatment
- Preventive care to maintain reproductive health

Our Microsurgical Excellence

As a specialist in male reproductive microsurgery, I maintain continuous professional development in the latest techniques. Our microsurgical capabilities include:

- Microsurgical varicocelectomy with lymphatic-sparing techniques
- Microsurgical testicular sperm extraction (MicroTESE)
- TeSE and Onco-TeSE (See Procedure Information)

Our operating suite is equipped with state-of-the-art surgical microscopes providing 20-25x magnification, specialised microsurgical instruments, and an experienced surgical team dedicated to reproductive procedures.

This comprehensive, systematic approach has allowed us to achieve optimal outcomes for men with even the most complex fertility challenges.

Contact and Appointment Information

Ready to take the first step toward understanding and addressing your fertility challenges? Our team at GGOmed, led by Mr. G Ollandini, is here to support you.

What to Expect at Your First Appointment: Your first consultation will be comprehensive, lasting 30-45 minutes. We'll begin with a detailed medical history review, followed by a physical examination if appropriate. Together, we'll discuss appropriate diagnostic tests and develop an initial treatment plan. There will be ample opportunity for you to ask questions and express concerns.

Insurance and Funding: We work with all major private health insurers and offer self-funding options. NHS referrals are accepted with appropriate funding approval. Our administrative team can provide detailed information about costs and payment options. Please refer to the Contact Page on GGOmed.co.uk for specific details on insurance and fees.

Take the first step on your fertility journey today

Book your comprehensive male fertility assessment with our specialist team.

Call:02045765779

Email My Team

This information is intended for educational purposes and does not replace personalised medical advice. Male fertility treatment should always be guided by a qualified healthcare professional.

Medical Evidence

National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG257. 2026.

Source:NICE.ORG.UK

World Health Organization. WHO laboratory manual for the examination and processing of human semen, sixth edition. Geneva: WHO; 2021.

Source:WHO.INT

European Association of Urology. EAU Guidelines on Sexual and Reproductive Health.

Source:UROWEB.ORG

Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril. 2015;103(3):e18-e25.

Source:DOI.ORG

Human Fertilisation and Embryology Authority. Treatment add-ons with limited evidence.

Source:HFEA.GOV.UK

Esteves SC, Miyaoka R, Agarwal A. An update on the clinical assessment of the infertile male. Clinics. 2011;66(4):691-700.

Source:DOI.ORG

Agarwal A, Majzoub A, Esteves SC, et al. Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios. Transl Androl Urol. 2016;5(6):935-950.

Source:DOI.ORG

Bernie AM, Ramasamy R, Schlegel PN. Predictive factors of successful microdissection testicular sperm extraction. Basic Clin Androl. 2013;23:5.

Source:DOI.ORG

Schlegel PN. Nonobstructive azoospermia: a revolutionary surgical approach and results. Semin Reprod Med. 2009;27(2):165-170.

Source:DOI.ORG

Corona G, Minhas S, Giwercman A, et al. Sperm recovery and ICSI outcomes in men with non-obstructive azoospermia: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(6):733-757.

Source:DOI.ORG

Kirby EW, Wiener LE, Rajanahally S, et al. Undergoing varicocele repair before assisted reproduction improves pregnancy rate and live birth rate in azoospermic and oligospermic men with a varicocele: a systematic review and meta-analysis. Fertil Steril. 2016;106(6):1338-1343.

Source:DOI.ORG

Showell MG, Mackenzie-Proctor R, Brown J, et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2014;(12):CD007411.

Source:DOI.ORG

Hamada A, Esteves SC, Agarwal A. A comprehensive review of genetics and genetic testing in azoospermia. Clinics. 2013;68(S1):39-60.

Source:DOI.ORG

Skakkebaek NE, Rajpert-De Meyts E, Buck Louis GM, et al. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol Rev. 2016;96(1):55-97.

Source:DOI.ORG

Majzoub A, Agarwal A. Systematic review of antioxidant types and doses in male infertility: benefits on semen parameters, advanced sperm function, assisted reproduction and live-birth rate. Arab J Urol. 2018;16(1):113-124.

Source:DOI.ORG

Oehninger S, Ombelet W. Limits of current male fertility testing. Fertil Steril. 2019;111(5):835-841.

Source:DOI.ORG

Esteves SC, Roque M, Bradley CK, Garrido N. Reproductive outcomes of testicular versus ejaculated sperm for intracytoplasmic sperm injection among men with high levels of DNA fragmentation in semen: systematic review and meta-analysis. Fertil Steril. 2017;108(3):456-467.

Source:DOI.ORG

Schlegel PN, Li PS. Microdissection TESE: sperm retrieval in non-obstructive azoospermia. Hum Reprod Update. 1998;4(4):439.

Source:DOI.ORG

Eisenberg ML, Meldrum D. Effects of age on fertility and sexual function. Fertil Steril. 2017;107(2):301-304.

Source:DOI.ORG

Leaver RB. Male infertility: an overview of causes and treatment options. Br J Nurs. 2016;25(18):S35-S40.

Source:DOI.ORG

Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15(6):369-384.

Source:DOI.ORG

Fisher JR, Hammarberg K. Psychological and social aspects of infertility in men: an overview of the evidence and implications for psychologically informed clinical care and future research. Asian J Androl. 2012;14(1):121-129.

Source:DOI.ORG

British Fertility Society: resources for patients and healthcare professionals on fertility.

Source:BRITISHFERTILITYSOCIETY.ORG.UK

Fertility Network UK: information and emotional support for people with fertility problems.

Source:FERTILITYNETWORKUK.ORG

Men's Health Forum: information on men's health, including fertility.

Source:MENSHEALTHFORUM.ORG.UK

Human Fertilisation and Embryology Authority (HFEA): the UK regulator, with impartial information about treatments and clinics.

Source:HFEA.GOV.UK

ReproductiveFacts.org (American Society for Reproductive Medicine): patient information on reproductive health.

Source:REPRODUCTIVEFACTS.ORG

RESOLVE: The National Infertility Association (US): patient advocacy and education.

Source:RESOLVE.ORG

Fertility Friends UK: online forum with sections on male factor infertility.

Source:FERTILITYFRIENDS.CO.UK

British Nutrition Foundation: evidence-based nutrition information.

Source:NUTRITION.ORG.UK

Tommy's: pre-conception advice for both partners.

Source:TOMMYS.ORG

Wingfield M. The Fertility Handbook. Dublin: Gill; 2017.

Majzoub A, Agarwal A, editors. The Complete Guide to Male Fertility Preservation. Cham: Springer; 2018.

Source:DOI.ORG

Lifestyle Modifications

Medical Treatments

When lifestyle changes aren't enough, various medications may help address the underlying causes of infertility.

For men experiencing erectile or ejaculatory dysfunction that impacts their ability to conceive, medications addressing these specific challenges can be valuable components of fertility treatment.

Surgical Interventions

Comprehensive Guide to Surgical Sperm Retrieval

Types of Surgical Sperm Retrieval

1. Percutaneous Epididymal Sperm Aspiration (PESA)

- Technique: Using a fine needle attached to a syringe, sperm is aspirated directly from the epididymis under local anaesthesia.
- Ideal for: Men with obstructive azoospermia (normal sperm production but blockage in the sperm transport system) such as: Congenital absence of vas deferens, Failed vasectomy reversal, Post-infection scarring.
- Advantages: Minimally invasive, Can be performed under local anaesthesia, Quick recovery.
- Limitations: May not retrieve enough sperm for cryopreservation, Not suitable for non-obstructive azoospermia, Risk of haematoma or fibrosis with repeated procedures.

1. Microsurgical Epididymal Sperm Aspiration (MESA)

- Technique: Open surgical procedure using an operating microscope to precisely identify and aspirate fluid from the epididymal tubules.
- Ideal for: Obstructive azoospermia when maximum sperm yield is desired.
- Advantages: Higher sperm yield than PESA, Usually retrieves enough sperm for freezing, Precise identification of epididymal tubules.
- Limitations: More invasive, Requires microsurgical expertise, Longer recovery time, Higher cost.

1. Testicular Sperm Aspiration (TESA)

- Technique: Fine-needle aspiration of testicular tissue using a needle and syringe.
- Ideal for: Obstructive azoospermia when epididymal approaches fail, Selected cases of non-obstructive azoospermia.
- Advantages: Relatively simple procedure, Can be performed under local anaesthesia, Minimal recovery time.
- Limitations: Lower sperm yield, Higher risk of retrieving immature sperm, Not ideal for severe testicular failure.

1. Conventional Testicular Sperm Extraction (TESE)

- Technique: Small incision in the testis to extract seminiferous tubules for processing and sperm extraction.
- Ideal for: Non-obstructive azoospermia with: Maturation arrest, Hypospermatogenesis, Focal areas of spermatogenesis.
- Advantages: Higher sperm yield than TESA, Good option for moderate testicular failure.
- Limitations: More invasive than aspiration techniques, Potential for testicular damage, Suboptimal for severe testicular failure.

1. Microdissection Testicular Sperm Extraction (MicroTESE)

- Technique: Advanced microsurgical procedure using high-powered magnification to identify and extract specific seminiferous tubules likely to contain sperm.
- Ideal for: Severe non-obstructive azoospermia, including: Sertoli cell-only syndrome, Severe hypospermatogenesis, Failed previous TESE, Klinefelter syndrome, Y-chromosome microdeletions (except AZFa and complete AZFb).
- Advantages: Highest sperm retrieval rates for severe cases (40-60% success even in challenging cases), Minimises testicular damage, Preserves testicular blood supply, Maximises sperm yield.
- Limitations: Requires specialised microsurgical expertise, Longer operating time, Higher cost, Limited availability in some regions.

The MicroTESE Procedure: A Closer Look

As a specialist in microsurgical techniques, I consider MicroTESE the gold standard for men with non-obstructive azoospermia. This sophisticated procedure involves:

1. Preparation: General anaesthesia, Midline scrotal incision, Delivery of the testis.
1. Equatorial Incision: The testis is opened along its equator under microscopic guidance. This approach provides a comprehensive view of the testicular architecture.
1. Microdissection (20-25x magnification): Careful examination of seminiferous tubules, Identification of larger, more opaque tubules (more likely to contain sperm), Selective extraction of promising tubules, Preservation of testicular blood supply, Immediate laboratory examination of extracted tissue.
1. Tissue Processing: Mechanical and enzymatic processing of extracted tissue, Identification of sperm under high-powered microscopy, Immediate use for ICSI or cryopreservation.
1. Closure: Meticulous layered closure of the tunica albuginea, Scrotal closure with absorbable sutures.

Factors Affecting Sperm Retrieval Success

1. Testicular Histology: Hypospermatogenesis: 73-100% success rate; Maturation arrest: 27-86% success rate; Sertoli cell-only syndrome: 27-50% success rate (with MicroTESE).
1. Hormonal Parameters: FSH levels: Not an absolute predictor, but very high levels may indicate lower chances; Testosterone levels: Higher preoperative levels correlate with better outcomes; Inhibin B: Higher levels generally predict better sperm retrieval rates.
1. Genetic Factors: Klinefelter syndrome: 40-70% success with MicroTESE; Y-chromosome microdeletions: Depends on the region affected (AZFc: 50-70% success; AZFa or complete AZFb: very poor prognosis).
1. Prior Treatments: Hormonal treatment before surgery is under study; NICE advises considering anti-oestrogen therapy only within a clinical trial for men without hypogonadotrophic hypogonadism.
1. Surgical Technique: MicroTESE consistently outperforms conventional TESE in difficult cases; Surgeon experience significantly impacts success rates.

Sperm Cryopreservation

Whenever possible, we recommend freezing extra sperm obtained during SSR procedures for future use. This approach:

- Avoids the need for repeated surgical procedures
- Provides psychological reassurance
- Allows for multiple IVF/ICSI cycles from a single retrieval
- Enables more flexible timing for the female partner's IVF cycle

Postoperative Care and Considerations

1. Physical Recovery: Rest for 24-48 hours; Ice packs to reduce swelling; Supportive underwear for 1-2 weeks; Avoidance of strenuous activity for 1-2 weeks; Sexual abstinence for 1-2 weeks.
1. Potential Complications: Haematoma (1-5%); Infection (rare); Testicular atrophy (rare with microsurgical techniques); Hypogonadism (temporary decline in testosterone possible).
1. Follow-up: Wound check at 1-2 weeks; Hormonal assessment at 3-6 months (especially after extensive procedures); Ultrasound may be performed to evaluate testicular integrity.
1. Long-term Considerations: Most men maintain normal testicular function after SSR; Repeated procedures may have cumulative effects on testicular function; Regular hormonal monitoring may be recommended for selected patients.

Considering surgical treatment?

Book a consultation to discuss which procedure might be right for you.

Assisted Reproductive Technologies (ART)

Assisted Reproductive Technologies: A Comprehensive Overview

Intrauterine Insemination (IUI)

The Process:

1. Sperm washing and concentration to select the most viable sperm
1. Direct placement of prepared sperm into the uterus via a thin catheter
1. Timed to coincide with ovulation (natural or stimulated)

Success Rates: 5-15% per cycle for male factor infertility; Cumulative pregnancy rates of 20-30% after 3-4 cycles; Beyond 4-6 unsuccessful cycles, progression to IVF/ICSI is usually recommended.

Advantages: Less invasive than IVF/ICSI; Lower cost; Reduced medication requirements; Can be performed during natural cycles.

Limitations: Not suitable for severe male factor infertility; Lower success rates compared to IVF/ICSI; Limited effectiveness with female factor infertility.

In Vitro Fertilisation (IVF)

The Process:

1. Ovarian stimulation and monitoring in the female partner
1. Egg retrieval under sedation
1. Sperm collection and preparation
1. Combining eggs and prepared sperm in laboratory conditions
1. Embryo culture for 3-5 days
1. Embryo transfer to the uterus
1. Luteal phase support and pregnancy testing

Advantages: Higher success rates than IUI; Allows assessment of fertilisation capability; Provides embryos for potential freezing and future use; Enables genetic testing of embryos if required.

Intracytoplasmic Sperm Injection (ICSI)

The Process:

1. Same steps as IVF for the female partner
1. Individual sperm selection under high magnification
1. Direct injection of a single sperm into each mature egg
1. Subsequent embryo culture, transfer, and monitoring as per IVF

Advanced Sperm Selection Techniques

1. Physiological Intracytoplasmic Sperm Injection (PICSI): Uses hyaluronic acid binding to select mature sperm. The HFEA rates PICSI black for patients having ICSI for male factor infertility: moderate to high quality evidence shows it has no effect on the chance of having a baby.
1. Intracytoplasmic Morphologically Selected Sperm Injection (IMSI): Uses high-power microscopy to select sperm by the appearance of the head. The HFEA rates IMSI grey: there is not enough good-quality evidence to say whether it improves the chance of having a baby.
1. Microfluidic Sperm Sorting: Uses sperm's natural ability to swim against a fluid current to select the most progressively motile sperm. Whether this improves the chance of having a baby has not been established.
1. Magnetic-Activated Cell Sorting (MACS): Separates apoptotic (programmed for cell death) from healthy sperm. The HFEA rates MACS with ICSI grey for male factor infertility: there is not enough good-quality evidence that it improves the chance of having a baby.

Surgical Sperm Retrieval with ICSI

For men with azoospermia (no sperm in the ejaculate), the combination of surgical sperm retrieval and ICSI has created a pathway to biological fatherhood:

Decision-Making: Choosing the Right ART Approach

The decision pathway typically follows this progression:

1. For mild male factor with good total motile count: Consider IUI first (3-4 cycles)
1. For moderate male factor or failed IUI: Progress to IVF
1. For severe male factor or poor fertilisation with standard IVF: ICSI is the treatment of choice
1. For azoospermia: Surgical sperm retrieval with ICSI

By understanding these options in detail, you can have more productive discussions with your fertility specialist and make informed decisions about your treatment journey.

Discuss Success Rates

We're Struggling to Conceive

Concerned about your fertility?

What is Male Factor Infertility?

The Science Behind Male Reproduction (Click to expand)

Common Causes of Male Infertility

In-Depth: Understanding the Causes of Male Infertility (Click to expand)

Genetic Factors

Hormonal Disorders

Structural Issues

Testicular Factors

Immunological Factors

Lifestyle and Environmental Factors

Idiopathic Infertility

Diagnosis: How We Assess Male Fertility

Need a comprehensive fertility assessment?

Understanding Your Semen Analysis

What the new WHO infertility guideline means for men

In-Depth: The Complete Guide to Semen Analysis (Click to expand)

The Semen Analysis Process

Treatment Options for Male Infertility

Lifestyle Modifications

Medical Treatments

Surgical Interventions

In-Depth: Surgical Sperm Retrieval Techniques (Click to expand)

Comprehensive Guide to Surgical Sperm Retrieval

Considering surgical treatment?

Assisted Reproductive Technologies (ART)

In-Depth: Assisted Reproductive Technologies for Male Factor Infertility (Click to expand)

Assisted Reproductive Technologies: A Comprehensive Overview

Emotional Support and Counselling

The Emotional Impact of Male Infertility (Click to expand)

Understanding and Managing the Emotional Journey

Need emotional support during your fertility journey?

Myths vs. Facts About Male Fertility

Myth: Infertility is usually a female issue

Myth: You can tell a man is fertile by his physical appearance

Myth: Age doesn't affect male fertility

Myth: Boxers vs. briefs significantly impact fertility

Myth: Supplements and vitamins can cure male infertility

Frequently Asked Questions

How long should we try to conceive before seeking help?

Can lifestyle changes really improve sperm quality?

Will I need to see a fertility specialist, or can my GP help?

Is ICSI always necessary for male factor infertility?

How successful is surgical sperm retrieval?

Will my insurance cover fertility treatments?

Your Journey to Fatherhood: Taking the Next Steps

Ready to start your fertility journey?

About Our Male Fertility Clinic

Our Treatment Approach (Click to expand)

Our Philosophy and Methodology

Contact and Appointment Information

Take the first step on your fertility journey today

Evidence & Medical Sources33 Sources

National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG257. 2026.

World Health Organization. WHO laboratory manual for the examination and processing of human semen, sixth edition. Geneva: WHO; 2021.

European Association of Urology. EAU Guidelines on Sexual and Reproductive Health.

Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril. 2015;103(3):e18-e25.

Human Fertilisation and Embryology Authority. Treatment add-ons with limited evidence.

Esteves SC, Miyaoka R, Agarwal A. An update on the clinical assessment of the infertile male. Clinics. 2011;66(4):691-700.

Agarwal A, Majzoub A, Esteves SC, et al. Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios. Transl Androl Urol. 2016;5(6):935-950.

Bernie AM, Ramasamy R, Schlegel PN. Predictive factors of successful microdissection testicular sperm extraction. Basic Clin Androl. 2013;23:5.

Schlegel PN. Nonobstructive azoospermia: a revolutionary surgical approach and results. Semin Reprod Med. 2009;27(2):165-170.

Corona G, Minhas S, Giwercman A, et al. Sperm recovery and ICSI outcomes in men with non-obstructive azoospermia: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(6):733-757.

Kirby EW, Wiener LE, Rajanahally S, et al. Undergoing varicocele repair before assisted reproduction improves pregnancy rate and live birth rate in azoospermic and oligospermic men with a varicocele: a systematic review and meta-analysis. Fertil Steril. 2016;106(6):1338-1343.

Showell MG, Mackenzie-Proctor R, Brown J, et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2014;(12):CD007411.

Hamada A, Esteves SC, Agarwal A. A comprehensive review of genetics and genetic testing in azoospermia. Clinics. 2013;68(S1):39-60.

Skakkebaek NE, Rajpert-De Meyts E, Buck Louis GM, et al. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol Rev. 2016;96(1):55-97.

Majzoub A, Agarwal A. Systematic review of antioxidant types and doses in male infertility: benefits on semen parameters, advanced sperm function, assisted reproduction and live-birth rate. Arab J Urol. 2018;16(1):113-124.

Oehninger S, Ombelet W. Limits of current male fertility testing. Fertil Steril. 2019;111(5):835-841.

Esteves SC, Roque M, Bradley CK, Garrido N. Reproductive outcomes of testicular versus ejaculated sperm for intracytoplasmic sperm injection among men with high levels of DNA fragmentation in semen: systematic review and meta-analysis. Fertil Steril. 2017;108(3):456-467.

Schlegel PN, Li PS. Microdissection TESE: sperm retrieval in non-obstructive azoospermia. Hum Reprod Update. 1998;4(4):439.

Eisenberg ML, Meldrum D. Effects of age on fertility and sexual function. Fertil Steril. 2017;107(2):301-304.

Leaver RB. Male infertility: an overview of causes and treatment options. Br J Nurs. 2016;25(18):S35-S40.

Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15(6):369-384.

Fisher JR, Hammarberg K. Psychological and social aspects of infertility in men: an overview of the evidence and implications for psychologically informed clinical care and future research. Asian J Androl. 2012;14(1):121-129.

British Fertility Society: resources for patients and healthcare professionals on fertility.

Fertility Network UK: information and emotional support for people with fertility problems.

Men's Health Forum: information on men's health, including fertility.

Human Fertilisation and Embryology Authority (HFEA): the UK regulator, with impartial information about treatments and clinics.